Related Experiment Video
Updated: Jun 5, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Deep vein thrombosis in protein S deficiency
1Norvic International Hospital, Thapathali, Kathmandu, Nepal. abhashjoshi221@gmail.com
Protein S deficiency, a rare condition affecting blood clotting, can cause deep vein thrombosis (DVT). This case highlights DVT in a 53-year-old male, emphasizing the need for timely diagnosis and management of this anticoagulant protein disorder.
Area of Science:
- Hematology
- Vascular Medicine
- Genetics
Background:
- Protein S is a crucial vitamin K-dependent anticoagulant protein.
- It acts as a cofactor for activated protein C, inhibiting factors Va and VIIIa.
- Protein S deficiency, though rare, increases thrombosis risk.
Observation:
- This case report details a 53-year-old male diagnosed with deep vein thrombosis (DVT).
- The DVT was attributed to a deficiency in Protein S.
- Diagnosis was confirmed via Venous Doppler and free Protein S level measurement (ELISA).
Findings:
- The patient presented with DVT, a serious condition linked to Protein S deficiency.
- Both hereditary and acquired forms of Protein S deficiency can lead to thrombotic events.
- Thrombosis manifestations occur in both heterozygous and homozygous deficiencies.
Implications:
- Early diagnosis and management of Protein S deficiency are vital to prevent severe thrombotic events like DVT, pulmonary embolism, and stroke.
- Long-term anticoagulant therapy is a common treatment for Protein S deficiency.
- This case underscores the importance of considering Protein S deficiency in unexplained thrombosis.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins

